Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Gero Luschin"'
Autor:
Marion Habersack, Gero Luschin
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e81770 (2013)
OBJECTIVES: Only 1.2%-11% of all potential study participants participate in cancer studies. Low participation rates can result in bias or in a failure to obtain data saturation. Subject-scientific psychology assumes that reasons for acting are based
Externí odkaz:
https://doaj.org/article/55b907733ea54f218fb4275abbb0f0a0
Publikováno v:
Clinical Oral Investigations. 18:401-407
The definite incidence rate of bisphosphonate-related osteonecrosis of the jaws (BRONJ) is still unknown. The aim of this study was to investigate prevalence of BRONJ in a group of breast cancer patients applying the classification of the Association
Autor:
Gero Luschin, Marion Habersack
Publikováno v:
Health Communication. 29:421-426
This study was initiated to identify how physicians inform women about specific side effects of endocrine therapy for early breast cancer. It is recommended that women with early breast cancer receive endocrine treatment for at least 5 years. Althoug
Autor:
Gero Luschin
Publikováno v:
Wiener Medizinische Wochenschrift. 160:497-500
Complete axillary lymph node dissection has been the traditional operation to determine whether cancer has spread beyond the breast. In the large majority of patients with breast cancer, lymphatic mapping and γ-probe-guided and/or blue dye sentinel
Autor:
Gerhard Friedrich, Gero Luschin, Alfred Beham, Farid Moinfar, Fattaneh A. Tavassoli, Andelko Hrzenjak, Alexander Deutsch
Publikováno v:
Modern Pathology. 21:639-646
Genetic abnormalities in microenvironmental tissues with subsequent alterations of reciprocal interactions between epithelial and mesenchymal cells play a key role in the breast carcinogenesis. Although a few reports have demonstrated abnormal fibrob
Autor:
Brigitte, Mlineritsch, Christoph, Tausch, Christian, Singer, Gero, Luschin-Ebengreuth, Raimund, Jakesz, Ferdinand, Ploner, Michael, Stierer, Elisabeth, Melbinger, Christian, Menzel, Andrea, Urbania, Michael, Fridrik, Günther, Steger, Peter, Wohlmuth, Michael, Gnant, Richard, Greil, G, Wahl
Publikováno v:
Breast Cancer Research and Treatment. 112:203-213
Background A multicenter phase II study was conducted to analyze the clinical activity of the steroidal aromatase inhibitor exemestane in the neoadjuvant treatment of post-menopausal women with strongly ER- and/or PgR- positive operable breast cancer
Publikováno v:
BMC Medical Research Methodology, Vol 12, Iss 1, p 25 (2012)
BMC Medical Research Methodology
BMC Medical Research Methodology
Background A special challenge for research studies of breast cancer among females is low patient participation rates. We compiled this systematic review to identify reasons why women with, or at high risk of, breast cancer do or do not participate i
Autor:
Gero, Luschin
Publikováno v:
Wiener medizinische Wochenschrift (1946). 160(19-20)
Complete axillary lymph node dissection has been the traditional operation to determine whether cancer has spread beyond the breast. In the large majority of patients with breast cancer, lymphatic mapping and γ-probe-guided and/or blue dye sentinel
Autor:
Michael, Gnant, Brigitte, Mlineritsch, Walter, Schippinger, Gero, Luschin-Ebengreuth, Sabine, Pöstlberger, Christian, Menzel, Raimund, Jakesz, Michael, Seifert, Michael, Hubalek, Vesna, Bjelic-Radisic, Hellmut, Samonigg, Christoph, Tausch, Holger, Eidtmann, Günther, Steger, Werner, Kwasny, Peter, Dubsky, Michael, Fridrik, Florian, Fitzal, Michael, Stierer, Ernst, Rücklinger, Richard, Greil, D, Reschke
Publikováno v:
The New England journal of medicine. 360(7)
The combination of ovarian suppression and tamoxifen is a standard adjuvant endocrine therapy in premenopausal women with endocrine-responsive breast cancer. Several reports have demonstrated that adjuvant endocrine therapy with aromatase inhibitors
Autor:
Michael, Gnant, Brigitte, Mlineritsch, Gero, Luschin-Ebengreuth, Franz, Kainberger, Helmut, Kässmann, Jutta Claudia, Piswanger-Sölkner, Michael, Seifert, Ferdinand, Ploner, Christian, Menzel, Peter, Dubsky, Florian, Fitzal, Vesna, Bjelic-Radisic, Günther, Steger, Richard, Greil, Christian, Marth, Ernst, Kubista, Hellmut, Samonigg, Peter, Wohlmuth, Martina, Mittlböck, Raimund, Jakesz, H L, Seewann
Publikováno v:
The Lancet. Oncology. 9(9)
The Austrian Breast and Colorectal Cancer Study Group trial-12 (ABCSG-12) bone substudy assesses zoledronic acid for preventing bone loss associated with adjuvant endocrine therapy and reports on long-term findings of bone-mineral density (BMD) durin